<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>The Nevada National Board Professional Learning Institute | Logan | Activity</title>
	<link>http://www.nationalboardinstitute.com/members/rockbrick9/activity/</link>
	<atom:link href="http://www.nationalboardinstitute.com/members/rockbrick9/activity/feed/" rel="self" type="application/rss+xml" />
	<description>Activity feed for Logan.</description>
	<lastBuildDate>Fri, 23 May 2025 17:06:54 -0700</lastBuildDate>
	<generator>https://buddypress.org/?v=9.1.1</generator>
	<language>en-US</language>
	<ttl>30</ttl>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>2</sy:updateFrequency>
	
						<item>
				<guid isPermaLink="false">17729095779636fcc10d6febb9adf780</guid>
				<title>Logan posted an update: Further, membrane-modified MSCs exhibited a better [&#133;]</title>
				<link>http://www.nationalboardinstitute.com/activity/p/40932/</link>
				<pubDate>Fri, 07 Feb 2025 10:01:30 -0800</pubDate>

									<content:encoded><![CDATA[<p>Further, membrane-modified MSCs exhibited a better therapeutic effect than wide-type MSCs in a rabbit model of PCD. Thus, this unique cell membrane modification strategy provides a new cell-based therapeutic approach for the early treatment of articular cartilage defects and other joint diseases.Severe peripheral nerve injuries often result in&hellip;<span class="activity-read-more" id="activity-read-more-40932"><a href="http://www.nationalboardinstitute.com/activity/p/40932/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">7e076117d8c5ccd90ad6440eb1badc90</guid>
				<title>Logan posted an update: Adolescents living with perinatally acquired HIV have low [&#133;]</title>
				<link>http://www.nationalboardinstitute.com/activity/p/38955/</link>
				<pubDate>Wed, 05 Feb 2025 09:34:38 -0800</pubDate>

									<content:encoded><![CDATA[<p>Adolescents living with perinatally acquired HIV have low rates of retention in care and viral suppression after the transition from paediatric to adult care. In this study, we developed and validated a tool to identify adolescent transition readiness.</p>
<p> We developed the HIV Adolescent Readiness for Transition Scale (HARTS) from June 2016 to&hellip;<span class="activity-read-more" id="activity-read-more-38955"><a href="http://www.nationalboardinstitute.com/activity/p/38955/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">480316d5164b0d91291d6f5cb41bdf24</guid>
				<title>Logan posted an update: Hydrophilic polymers that swell or dissolve in aqueous media [&#133;]</title>
				<link>http://www.nationalboardinstitute.com/activity/p/37310/</link>
				<pubDate>Mon, 03 Feb 2025 09:54:16 -0800</pubDate>

									<content:encoded><![CDATA[<p>Hydrophilic polymers that swell or dissolve in aqueous media can have the potential to prepare controlled/sustained dosage forms for weakly acidic, poorly soluble drugs.</p>
<p> The main objective of this study is to utilize Eudragit®E100 (EE) and Carbopol®971P NF (Cp) polymers and their salt forms in the preparation of a once-daily c&hellip;<span class="activity-read-more" id="activity-read-more-37310"><a href="http://www.nationalboardinstitute.com/activity/p/37310/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">c7d85bdea83f9c2b187c93631e33daa4</guid>
				<title>Logan posted an update: There was no report of adverse events. Findings from this [&#133;]</title>
				<link>http://www.nationalboardinstitute.com/activity/p/33498/</link>
				<pubDate>Thu, 30 Jan 2025 09:36:52 -0800</pubDate>

									<content:encoded><![CDATA[<p>There was no report of adverse events. Findings from this retrospective, exploratory study suggest that safinamide 100 mg may produce more powerful benefit that rasagiline 1 mg as add-on to levodopa in fluctuating PD patients, possibly because of the bimodal mechanism of action of the former drug.This study compared the presence of pain in&hellip;<span class="activity-read-more" id="activity-read-more-33498"><a href="http://www.nationalboardinstitute.com/activity/p/33498/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">89f7cd092367d858e2a5810b2964a248</guid>
				<title>Logan posted an update: Circular RNA (circRNA) is an intriguing class of RNA with [&#133;]</title>
				<link>http://www.nationalboardinstitute.com/activity/p/30238/</link>
				<pubDate>Tue, 28 Jan 2025 14:57:49 -0800</pubDate>

									<content:encoded><![CDATA[<p>Circular RNA (circRNA) is an intriguing class of RNA with covalently closed-loop structure and is highly stable and conservative. As new members of the ncRNAs, the function, mechanism, potential diagnostic biomarker, and therapeutic target have raised increased attention. Most circRNAs are presented with characteristics of abundance, stability,&hellip;<span class="activity-read-more" id="activity-read-more-30238"><a href="http://www.nationalboardinstitute.com/activity/p/30238/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
		
	</channel>
</rss>